Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.99210080 |
2 | positive regulation of protein homooligomerization (GO:0032464) | 3.90378338 |
3 | iron-sulfur cluster assembly (GO:0016226) | 3.50132175 |
4 | metallo-sulfur cluster assembly (GO:0031163) | 3.50132175 |
5 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.47595513 |
6 | viral protein processing (GO:0019082) | 3.32935233 |
7 | protein maturation by protein folding (GO:0022417) | 3.26786897 |
8 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 3.25620402 |
9 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.24271570 |
10 | protein complex biogenesis (GO:0070271) | 3.19166852 |
11 | regulation of oxidative phosphorylation (GO:0002082) | 3.14272189 |
12 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.11764030 |
13 | proteasome assembly (GO:0043248) | 3.05454166 |
14 | peroxisome fission (GO:0016559) | 3.02342673 |
15 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.98477489 |
16 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.97347855 |
17 | respiratory electron transport chain (GO:0022904) | 2.93718863 |
18 | cytidine catabolic process (GO:0006216) | 2.92524415 |
19 | cytidine deamination (GO:0009972) | 2.92524415 |
20 | cytidine metabolic process (GO:0046087) | 2.92524415 |
21 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.91836710 |
22 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.91836710 |
23 | electron transport chain (GO:0022900) | 2.89071236 |
24 | virion assembly (GO:0019068) | 2.85946725 |
25 | protein targeting to mitochondrion (GO:0006626) | 2.84441128 |
26 | organelle membrane fusion (GO:0090174) | 2.84002596 |
27 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.81473819 |
28 | GDP-mannose metabolic process (GO:0019673) | 2.81097572 |
29 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.80143211 |
30 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.79459972 |
31 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.78219036 |
32 | protein neddylation (GO:0045116) | 2.77675088 |
33 | positive regulation of mitochondrial fission (GO:0090141) | 2.75436992 |
34 | positive regulation of protein oligomerization (GO:0032461) | 2.71968858 |
35 | base-excision repair, AP site formation (GO:0006285) | 2.70789127 |
36 | establishment of protein localization to mitochondrion (GO:0072655) | 2.70726979 |
37 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.69645457 |
38 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.69645457 |
39 | NADH dehydrogenase complex assembly (GO:0010257) | 2.69645457 |
40 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.63796586 |
41 | cellular response to interleukin-15 (GO:0071350) | 2.63399206 |
42 | NIK/NF-kappaB signaling (GO:0038061) | 2.63056529 |
43 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.61768487 |
44 | DNA deamination (GO:0045006) | 2.61202148 |
45 | protein localization to mitochondrion (GO:0070585) | 2.59512917 |
46 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.56993314 |
47 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.55481740 |
48 | purine nucleotide salvage (GO:0032261) | 2.53168329 |
49 | autophagic vacuole fusion (GO:0000046) | 2.53160517 |
50 | piRNA metabolic process (GO:0034587) | 2.51781938 |
51 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.51584041 |
52 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.51206086 |
53 | regulation of mitochondrial translation (GO:0070129) | 2.50581807 |
54 | entrainment of circadian clock by photoperiod (GO:0043153) | 2.49376516 |
55 | regulation of cellular respiration (GO:0043457) | 2.48926080 |
56 | heart contraction (GO:0060047) | 2.48650505 |
57 | heart process (GO:0003015) | 2.48650505 |
58 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.48120110 |
59 | negative regulation of cell killing (GO:0031342) | 2.48120110 |
60 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.48030783 |
61 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.47936557 |
62 | regulation of protein homooligomerization (GO:0032462) | 2.47509467 |
63 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.47418677 |
64 | leukocyte degranulation (GO:0043299) | 2.46510510 |
65 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.46478259 |
66 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.46478259 |
67 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.45256934 |
68 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.44332650 |
69 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.43928519 |
70 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.43928519 |
71 | nucleotide salvage (GO:0043173) | 2.43469493 |
72 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.43405569 |
73 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.40100545 |
74 | ATP synthesis coupled proton transport (GO:0015986) | 2.40100545 |
75 | immunoglobulin mediated immune response (GO:0016064) | 2.39823842 |
76 | chaperone-mediated protein transport (GO:0072321) | 2.39297690 |
77 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.39084188 |
78 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.39084188 |
79 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.39084188 |
80 | ribosomal small subunit biogenesis (GO:0042274) | 2.38779673 |
81 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.35808954 |
82 | neutrophil activation involved in immune response (GO:0002283) | 2.35716539 |
83 | phagosome maturation (GO:0090382) | 2.35575835 |
84 | male meiosis I (GO:0007141) | 2.34673414 |
85 | mast cell activation involved in immune response (GO:0002279) | 2.33686074 |
86 | mast cell degranulation (GO:0043303) | 2.33686074 |
87 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.33663712 |
88 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.33663712 |
89 | positive regulation of ligase activity (GO:0051351) | 2.29944583 |
90 | transferrin transport (GO:0033572) | 2.28911510 |
91 | release of cytochrome c from mitochondria (GO:0001836) | 2.28411568 |
92 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.27153227 |
93 | negative regulation of ligase activity (GO:0051352) | 2.27153227 |
94 | meiosis I (GO:0007127) | 2.25952392 |
95 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.25375742 |
96 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.24705598 |
97 | response to peptidoglycan (GO:0032494) | 2.24679822 |
98 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.24307617 |
99 | T cell migration (GO:0072678) | 2.23217529 |
100 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.22306980 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.51963917 |
2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.78824747 |
3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.68630887 |
4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.28847984 |
5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.15918151 |
6 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.03187727 |
7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.99035461 |
8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.88324995 |
9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.66391626 |
10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.45122732 |
11 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.44612348 |
12 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.41170262 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.36511075 |
14 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.33702828 |
15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.28916493 |
16 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.16466005 |
17 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08113135 |
18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.05761132 |
19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.05537546 |
20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.04903814 |
21 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.02816582 |
22 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.99507330 |
23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93815779 |
24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.86098395 |
25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.84824226 |
26 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82950868 |
27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.78318439 |
28 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.78259248 |
29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.72327448 |
30 | MAF_26560356_Chip-Seq_TH2_Human | 1.70168648 |
31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69128017 |
32 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.67722265 |
33 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.67187669 |
34 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.67122336 |
35 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.66452681 |
36 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.66396687 |
37 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.65390534 |
38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.64283109 |
39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.63741544 |
40 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.57810991 |
41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55609146 |
42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53786673 |
43 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.51697435 |
44 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.50048155 |
45 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49880761 |
46 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49526385 |
47 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.49460213 |
48 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.47324848 |
49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.47101439 |
50 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.45714685 |
51 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.43627789 |
52 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.43137169 |
53 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.42137788 |
54 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.41267652 |
55 | MYC_22102868_ChIP-Seq_BL_Human | 1.41154406 |
56 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.38563643 |
57 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.36294052 |
58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35476872 |
59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.33877512 |
60 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.32848297 |
61 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.32807910 |
62 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.31424348 |
63 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.30368673 |
64 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30118136 |
65 | MAF_26560356_Chip-Seq_TH1_Human | 1.29704819 |
66 | MYB_26560356_Chip-Seq_TH2_Human | 1.28092548 |
67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26759419 |
68 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.25281578 |
69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23335159 |
70 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.22174926 |
71 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.21040290 |
72 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.20504083 |
73 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.20137674 |
74 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.15325043 |
75 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15184691 |
76 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.15085465 |
77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14182000 |
78 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.13775277 |
79 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.12878041 |
80 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.12787039 |
81 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11615086 |
82 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.10615476 |
83 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09736496 |
84 | P68_20966046_ChIP-Seq_HELA_Human | 1.09641888 |
85 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.09323389 |
86 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07428386 |
87 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.06769490 |
88 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.06407127 |
89 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06187462 |
90 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.05869894 |
91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04593539 |
92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03649856 |
93 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03474248 |
94 | P300_27268052_Chip-Seq_Bcells_Human | 1.03347786 |
95 | MYB_26560356_Chip-Seq_TH1_Human | 1.02648311 |
96 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02393173 |
97 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.01733510 |
98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01119679 |
99 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.00626564 |
100 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.99427512 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005671_abnormal_response_to | 3.10501211 |
2 | MP0005058_abnormal_lysosome_morphology | 2.99044803 |
3 | MP0006036_abnormal_mitochondrial_physio | 2.80380929 |
4 | MP0003806_abnormal_nucleotide_metabolis | 2.79023081 |
5 | MP0005451_abnormal_body_composition | 2.64260964 |
6 | MP0001790_abnormal_immune_system | 2.51056476 |
7 | MP0005387_immune_system_phenotype | 2.51056476 |
8 | MP0001835_abnormal_antigen_presentation | 2.48922356 |
9 | MP0000749_muscle_degeneration | 2.46975797 |
10 | MP0001800_abnormal_humoral_immune | 2.32207182 |
11 | MP0003763_abnormal_thymus_physiology | 2.29517471 |
12 | MP0005000_abnormal_immune_tolerance | 2.27227405 |
13 | MP0009785_altered_susceptibility_to | 2.24717963 |
14 | MP0008260_abnormal_autophagy | 2.21223605 |
15 | MP0009333_abnormal_splenocyte_physiolog | 2.21190237 |
16 | MP0000685_abnormal_immune_system | 2.13140464 |
17 | MP0003436_decreased_susceptibility_to | 2.09306634 |
18 | MP0002723_abnormal_immune_serum | 2.06044364 |
19 | MP0002132_abnormal_respiratory_system | 2.03758973 |
20 | MP0005025_abnormal_response_to | 1.90959058 |
21 | MP0009840_abnormal_foam_cell | 1.87243300 |
22 | MP0003172_abnormal_lysosome_physiology | 1.85581597 |
23 | MP0002420_abnormal_adaptive_immunity | 1.85267339 |
24 | MP0002148_abnormal_hypersensitivity_rea | 1.84996866 |
25 | MP0001819_abnormal_immune_cell | 1.82091912 |
26 | MP0002163_abnormal_gland_morphology | 1.81065433 |
27 | MP0002452_abnormal_antigen_presenting | 1.80681391 |
28 | MP0003786_premature_aging | 1.75325233 |
29 | MP0003186_abnormal_redox_activity | 1.66322760 |
30 | MP0002277_abnormal_respiratory_mucosa | 1.63995667 |
31 | MP0008789_abnormal_olfactory_epithelium | 1.60412512 |
32 | MP0001845_abnormal_inflammatory_respons | 1.59038444 |
33 | MP0002398_abnormal_bone_marrow | 1.58273789 |
34 | MP0000372_irregular_coat_pigmentation | 1.56847901 |
35 | MP0000716_abnormal_immune_system | 1.53395447 |
36 | MP0008995_early_reproductive_senescence | 1.48584243 |
37 | MP0005499_abnormal_olfactory_system | 1.39417625 |
38 | MP0005394_taste/olfaction_phenotype | 1.39417625 |
39 | MP0001727_abnormal_embryo_implantation | 1.38971315 |
40 | MP0003866_abnormal_defecation | 1.38597832 |
41 | MP0002419_abnormal_innate_immunity | 1.38351147 |
42 | MP0000689_abnormal_spleen_morphology | 1.37750053 |
43 | MP0000703_abnormal_thymus_morphology | 1.34831127 |
44 | MP0003724_increased_susceptibility_to | 1.33985250 |
45 | MP0002429_abnormal_blood_cell | 1.33441401 |
46 | MP0000015_abnormal_ear_pigmentation | 1.33177392 |
47 | MP0006035_abnormal_mitochondrial_morpho | 1.32722775 |
48 | MP0002722_abnormal_immune_system | 1.32691108 |
49 | MP0000678_abnormal_parathyroid_gland | 1.31359332 |
50 | MP0004233_abnormal_muscle_weight | 1.30903300 |
51 | MP0010155_abnormal_intestine_physiology | 1.29473225 |
52 | MP0002139_abnormal_hepatobiliary_system | 1.23673640 |
53 | MP0000343_altered_response_to | 1.22128559 |
54 | MP0005464_abnormal_platelet_physiology | 1.19244520 |
55 | MP0008469_abnormal_protein_level | 1.17606277 |
56 | MP0008058_abnormal_DNA_repair | 1.15110422 |
57 | MP0002138_abnormal_hepatobiliary_system | 1.14378325 |
58 | MP0000490_abnormal_crypts_of | 1.12244725 |
59 | MP0004510_myositis | 1.09623727 |
60 | MP0001873_stomach_inflammation | 1.09475342 |
61 | MP0003693_abnormal_embryo_hatching | 1.09300242 |
62 | MP0008004_abnormal_stomach_pH | 1.08973959 |
63 | MP0001764_abnormal_homeostasis | 1.08497446 |
64 | MP0002210_abnormal_sex_determination | 1.07772661 |
65 | MP0000750_abnormal_muscle_regeneration | 1.07677610 |
66 | MP0002332_abnormal_exercise_endurance | 1.07499515 |
67 | MP0001929_abnormal_gametogenesis | 1.00969719 |
68 | MP0002405_respiratory_system_inflammati | 0.98675875 |
69 | MP0005319_abnormal_enzyme/_coenzyme | 0.98654785 |
70 | MP0001853_heart_inflammation | 0.98458316 |
71 | MP0001529_abnormal_vocalization | 0.97348125 |
72 | MP0003646_muscle_fatigue | 0.93523249 |
73 | MP0003191_abnormal_cellular_cholesterol | 0.93219447 |
74 | MP0005330_cardiomyopathy | 0.91858818 |
75 | MP0005075_abnormal_melanosome_morpholog | 0.89763705 |
76 | MP0000013_abnormal_adipose_tissue | 0.88173997 |
77 | MP0002837_dystrophic_cardiac_calcinosis | 0.86928929 |
78 | MP0000759_abnormal_skeletal_muscle | 0.85978093 |
79 | MP0002269_muscular_atrophy | 0.82577090 |
80 | MP0005310_abnormal_salivary_gland | 0.81678769 |
81 | MP0002693_abnormal_pancreas_physiology | 0.81618147 |
82 | MP0005410_abnormal_fertilization | 0.81066368 |
83 | MP0001905_abnormal_dopamine_level | 0.80817105 |
84 | MP0003303_peritoneal_inflammation | 0.79360951 |
85 | MP0004381_abnormal_hair_follicle | 0.78937130 |
86 | MP0006082_CNS_inflammation | 0.78564936 |
87 | MP0001145_abnormal_male_reproductive | 0.74227501 |
88 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73927197 |
89 | MP0000653_abnormal_sex_gland | 0.73012945 |
90 | MP0000751_myopathy | 0.71961730 |
91 | MP0000313_abnormal_cell_death | 0.70242738 |
92 | MP0005266_abnormal_metabolism | 0.70143325 |
93 | MP0003698_abnormal_male_reproductive | 0.69176723 |
94 | MP0000747_muscle_weakness | 0.67559365 |
95 | MP0002933_joint_inflammation | 0.67030063 |
96 | MP0005166_decreased_susceptibility_to | 0.65033615 |
97 | MP0005379_endocrine/exocrine_gland_phen | 0.64892760 |
98 | MP0009643_abnormal_urine_homeostasis | 0.64627960 |
99 | MP0000858_altered_metastatic_potential | 0.63827652 |
100 | MP0002160_abnormal_reproductive_system | 0.63272935 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.38430556 |
2 | Acute necrotizing encephalopathy (HP:0006965) | 4.26251170 |
3 | Mitochondrial inheritance (HP:0001427) | 3.69629023 |
4 | Progressive macrocephaly (HP:0004481) | 3.60830701 |
5 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.56441073 |
6 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.56441073 |
7 | Hepatocellular necrosis (HP:0001404) | 3.43352155 |
8 | Acute encephalopathy (HP:0006846) | 3.30579832 |
9 | Hepatic necrosis (HP:0002605) | 3.22359673 |
10 | Increased CSF lactate (HP:0002490) | 3.21315140 |
11 | Cholecystitis (HP:0001082) | 3.06613338 |
12 | Abnormal gallbladder physiology (HP:0012438) | 3.06613338 |
13 | Increased intramyocellular lipid droplets (HP:0012240) | 3.03101157 |
14 | Exercise intolerance (HP:0003546) | 2.92538309 |
15 | Increased IgM level (HP:0003496) | 2.80967038 |
16 | Increased muscle lipid content (HP:0009058) | 2.72205465 |
17 | Abnormality of macrophages (HP:0004311) | 2.68133314 |
18 | Exercise-induced myalgia (HP:0003738) | 2.62838354 |
19 | Cerebral edema (HP:0002181) | 2.62395650 |
20 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.59515143 |
21 | Ragged-red muscle fibers (HP:0003200) | 2.59058537 |
22 | Renal Fanconi syndrome (HP:0001994) | 2.58560552 |
23 | Muscle fiber atrophy (HP:0100295) | 2.57643002 |
24 | Abnormality of lateral ventricle (HP:0030047) | 2.56799451 |
25 | Type I transferrin isoform profile (HP:0003642) | 2.56684251 |
26 | 3-Methylglutaconic aciduria (HP:0003535) | 2.55055726 |
27 | Lactic acidosis (HP:0003128) | 2.54416296 |
28 | Chronic diarrhea (HP:0002028) | 2.49495341 |
29 | Recurrent abscess formation (HP:0002722) | 2.44942757 |
30 | Rhabdomyolysis (HP:0003201) | 2.40834618 |
31 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.38240368 |
32 | Type 2 muscle fiber atrophy (HP:0003554) | 2.37762701 |
33 | Stomatitis (HP:0010280) | 2.35332466 |
34 | Generalized aminoaciduria (HP:0002909) | 2.33786713 |
35 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.31933348 |
36 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.31933348 |
37 | Abnormal protein glycosylation (HP:0012346) | 2.31933348 |
38 | Abnormal glycosylation (HP:0012345) | 2.31933348 |
39 | Reduced antithrombin III activity (HP:0001976) | 2.30839805 |
40 | Recurrent bacterial skin infections (HP:0005406) | 2.29557626 |
41 | Vacuolated lymphocytes (HP:0001922) | 2.26739689 |
42 | Recurrent cutaneous fungal infections (HP:0011370) | 2.24207236 |
43 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.24207236 |
44 | Respiratory failure (HP:0002878) | 2.23054188 |
45 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.20314630 |
46 | Seborrheic dermatitis (HP:0001051) | 2.19383551 |
47 | Recurrent fungal infections (HP:0002841) | 2.15469062 |
48 | Increased serum lactate (HP:0002151) | 2.14842427 |
49 | Bulbar palsy (HP:0001283) | 2.10255284 |
50 | Myopathic facies (HP:0002058) | 2.09882755 |
51 | Hypokinesia (HP:0002375) | 2.09104482 |
52 | X-linked dominant inheritance (HP:0001423) | 2.09021938 |
53 | Hypertensive crisis (HP:0100735) | 2.08835112 |
54 | Progressive muscle weakness (HP:0003323) | 2.08511800 |
55 | Dyschromatopsia (HP:0007641) | 2.07210347 |
56 | Acute hepatic failure (HP:0006554) | 2.05405136 |
57 | Dicarboxylic aciduria (HP:0003215) | 2.04194756 |
58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.04194756 |
59 | Gastrointestinal infarctions (HP:0005244) | 2.01933363 |
60 | Asymmetric septal hypertrophy (HP:0001670) | 2.01322653 |
61 | Myoglobinuria (HP:0002913) | 2.00472791 |
62 | Chronic obstructive pulmonary disease (HP:0006510) | 1.97950468 |
63 | Obstructive lung disease (HP:0006536) | 1.97950468 |
64 | Abnormality of glycolipid metabolism (HP:0010969) | 1.97453919 |
65 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.97453919 |
66 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.97453919 |
67 | Optic disc pallor (HP:0000543) | 1.96091485 |
68 | Abnormality of the anterior horn cell (HP:0006802) | 1.95335389 |
69 | Degeneration of anterior horn cells (HP:0002398) | 1.95335389 |
70 | Emotional lability (HP:0000712) | 1.95219465 |
71 | Microretrognathia (HP:0000308) | 1.92579863 |
72 | Fetal akinesia sequence (HP:0001989) | 1.91446032 |
73 | Joint swelling (HP:0001386) | 1.90549697 |
74 | Amniotic constriction ring (HP:0009775) | 1.90369794 |
75 | Abnormality of placental membranes (HP:0011409) | 1.90369794 |
76 | Respiratory difficulties (HP:0002880) | 1.90121331 |
77 | Cholelithiasis (HP:0001081) | 1.89699279 |
78 | Severe visual impairment (HP:0001141) | 1.89189874 |
79 | Easy fatigability (HP:0003388) | 1.88537379 |
80 | Secondary amenorrhea (HP:0000869) | 1.88415438 |
81 | Abnormality of T cells (HP:0002843) | 1.85737387 |
82 | Lethargy (HP:0001254) | 1.85464599 |
83 | Recurrent skin infections (HP:0001581) | 1.85207671 |
84 | Recurrent viral infections (HP:0004429) | 1.81083898 |
85 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.80532626 |
86 | Ketosis (HP:0001946) | 1.77809374 |
87 | Poor suck (HP:0002033) | 1.75374270 |
88 | Rimmed vacuoles (HP:0003805) | 1.74528020 |
89 | Albinism (HP:0001022) | 1.73858242 |
90 | Meningitis (HP:0001287) | 1.73545145 |
91 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.73031462 |
92 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.72771009 |
93 | Exercise-induced muscle cramps (HP:0003710) | 1.72621830 |
94 | Premature ovarian failure (HP:0008209) | 1.72208186 |
95 | Abnormality of T cell physiology (HP:0011840) | 1.70952549 |
96 | Abnormal gallbladder morphology (HP:0012437) | 1.70573463 |
97 | Lymphopenia (HP:0001888) | 1.69050805 |
98 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.67918210 |
99 | Cortical visual impairment (HP:0100704) | 1.67780654 |
100 | Panhypogammaglobulinemia (HP:0003139) | 1.67294042 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NME2 | 3.87215551 |
2 | VRK2 | 3.64405930 |
3 | STK16 | 2.98009210 |
4 | PDK2 | 2.58583236 |
5 | MAP4K1 | 2.53527228 |
6 | BCKDK | 2.40042631 |
7 | TESK1 | 2.36090714 |
8 | TESK2 | 2.31402867 |
9 | IRAK3 | 2.28970514 |
10 | RIPK4 | 2.26514569 |
11 | TXK | 2.00192313 |
12 | TBK1 | 1.95121292 |
13 | MARK3 | 1.89449787 |
14 | VRK1 | 1.87833289 |
15 | TYK2 | 1.81974243 |
16 | OBSCN | 1.81459841 |
17 | MUSK | 1.71118143 |
18 | ILK | 1.68171800 |
19 | PRPF4B | 1.63486717 |
20 | IRAK4 | 1.58731053 |
21 | IKBKE | 1.47924098 |
22 | ARAF | 1.46825859 |
23 | MAP2K7 | 1.46583868 |
24 | LIMK1 | 1.46091414 |
25 | IKBKB | 1.42109806 |
26 | TNK2 | 1.40794803 |
27 | KDR | 1.36340277 |
28 | EIF2AK3 | 1.35793279 |
29 | MAP3K13 | 1.35224018 |
30 | MAP3K12 | 1.35121505 |
31 | CSNK1G3 | 1.33363906 |
32 | TLK1 | 1.31520008 |
33 | TAOK3 | 1.30189455 |
34 | FES | 1.26340977 |
35 | EIF2AK1 | 1.25991851 |
36 | MST4 | 1.25570709 |
37 | PINK1 | 1.25445160 |
38 | PRKCQ | 1.19031182 |
39 | SIK3 | 1.17895323 |
40 | TRIM28 | 1.14529695 |
41 | MAP3K11 | 1.11287645 |
42 | NEK1 | 1.11136784 |
43 | LRRK2 | 1.10253396 |
44 | PRKCI | 0.99160307 |
45 | BMPR2 | 0.99001561 |
46 | CSNK1A1L | 0.98196861 |
47 | MAP3K14 | 0.94926900 |
48 | IRAK2 | 0.91086799 |
49 | CAMKK2 | 0.91016085 |
50 | SYK | 0.87970373 |
51 | MAPK12 | 0.87341803 |
52 | NME1 | 0.87211833 |
53 | CCNB1 | 0.86677930 |
54 | PHKG1 | 0.86213695 |
55 | PHKG2 | 0.86213695 |
56 | MAP2K3 | 0.86167675 |
57 | CDK9 | 0.84163941 |
58 | CSNK1G2 | 0.83677359 |
59 | GRK6 | 0.82349842 |
60 | PDK1 | 0.78311993 |
61 | MAP4K2 | 0.77833453 |
62 | ZAP70 | 0.73279474 |
63 | MAPK11 | 0.73002535 |
64 | BLK | 0.71523336 |
65 | PAK1 | 0.70965059 |
66 | RPS6KA5 | 0.66287369 |
67 | TAOK2 | 0.64176170 |
68 | CSNK1G1 | 0.64157937 |
69 | MATK | 0.62689110 |
70 | TRIB3 | 0.62619716 |
71 | PKN2 | 0.62375639 |
72 | DAPK1 | 0.62235379 |
73 | PDPK1 | 0.60871195 |
74 | MAP3K5 | 0.60459531 |
75 | BTK | 0.58450284 |
76 | MAPK15 | 0.57668182 |
77 | LYN | 0.57497863 |
78 | ERN1 | 0.57306429 |
79 | CSF1R | 0.57296598 |
80 | CDK19 | 0.56718867 |
81 | MAP2K6 | 0.55738074 |
82 | BUB1 | 0.53740183 |
83 | MAP3K1 | 0.49642838 |
84 | PIM2 | 0.49271613 |
85 | AURKA | 0.46927846 |
86 | CSK | 0.46785135 |
87 | CAMKK1 | 0.44733785 |
88 | JAK2 | 0.43075293 |
89 | STK10 | 0.41784681 |
90 | PRKD1 | 0.40341894 |
91 | SIK1 | 0.40058331 |
92 | ZAK | 0.39646306 |
93 | DAPK3 | 0.38345346 |
94 | SMG1 | 0.37853696 |
95 | MAP3K3 | 0.37706899 |
96 | KSR1 | 0.35682703 |
97 | ITK | 0.35366383 |
98 | MAPKAPK3 | 0.35206347 |
99 | CSNK2A1 | 0.34157470 |
100 | MAPKAPK2 | 0.32818856 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.80264522 |
2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.37804857 |
3 | Proteasome_Homo sapiens_hsa03050 | 3.24854000 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.61832895 |
5 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.54527390 |
6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.44871197 |
7 | Sulfur relay system_Homo sapiens_hsa04122 | 2.12238446 |
8 | Ribosome_Homo sapiens_hsa03010 | 2.10570241 |
9 | Huntingtons disease_Homo sapiens_hsa05016 | 2.06318641 |
10 | Alzheimers disease_Homo sapiens_hsa05010 | 2.01234786 |
11 | Protein export_Homo sapiens_hsa03060 | 1.89282939 |
12 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.80968270 |
13 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.78767802 |
14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.76022563 |
15 | RNA polymerase_Homo sapiens_hsa03020 | 1.70630958 |
16 | Allograft rejection_Homo sapiens_hsa05330 | 1.58135791 |
17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.56847446 |
18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56184129 |
19 | Base excision repair_Homo sapiens_hsa03410 | 1.54094702 |
20 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.50497536 |
21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.41287035 |
22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.39314063 |
23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37868250 |
24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.36103588 |
25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.34551179 |
26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.30363596 |
27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.24050382 |
28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.20662677 |
29 | Lysosome_Homo sapiens_hsa04142 | 1.20449495 |
30 | Measles_Homo sapiens_hsa05162 | 1.15369015 |
31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.15329829 |
32 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.12318201 |
33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.09583649 |
34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08957608 |
35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08800277 |
36 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.08547168 |
37 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.08497450 |
38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.06555285 |
39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.06387443 |
40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.05367023 |
41 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.02227257 |
42 | Peroxisome_Homo sapiens_hsa04146 | 1.01764030 |
43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.01602680 |
44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01180845 |
45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00321717 |
46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00095579 |
47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.00011052 |
48 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.95357527 |
49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.95030614 |
50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.94190794 |
51 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.92720898 |
52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.89755660 |
53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.88032540 |
54 | Apoptosis_Homo sapiens_hsa04210 | 0.85342326 |
55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85332105 |
56 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84879141 |
57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.84189612 |
58 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.84117445 |
59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.82906832 |
60 | Basal transcription factors_Homo sapiens_hsa03022 | 0.80580075 |
61 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79859246 |
62 | Tuberculosis_Homo sapiens_hsa05152 | 0.79690838 |
63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79018314 |
64 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.78962267 |
65 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.78094602 |
66 | RNA degradation_Homo sapiens_hsa03018 | 0.76168335 |
67 | Phagosome_Homo sapiens_hsa04145 | 0.76107720 |
68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76096557 |
69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73187057 |
70 | Purine metabolism_Homo sapiens_hsa00230 | 0.70884703 |
71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65895838 |
72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64416043 |
73 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62475875 |
74 | Influenza A_Homo sapiens_hsa05164 | 0.61664033 |
75 | Legionellosis_Homo sapiens_hsa05134 | 0.61017801 |
76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60262270 |
77 | Spliceosome_Homo sapiens_hsa03040 | 0.59856548 |
78 | Hepatitis B_Homo sapiens_hsa05161 | 0.59694516 |
79 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58954317 |
80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.57797535 |
81 | Asthma_Homo sapiens_hsa05310 | 0.57329640 |
82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57143341 |
83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.56829145 |
84 | Shigellosis_Homo sapiens_hsa05131 | 0.56190935 |
85 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.55979116 |
86 | Circadian rhythm_Homo sapiens_hsa04710 | 0.54588729 |
87 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.53950778 |
88 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.52975563 |
89 | RNA transport_Homo sapiens_hsa03013 | 0.51846623 |
90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51340489 |
91 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.49726260 |
92 | Endocytosis_Homo sapiens_hsa04144 | 0.49170468 |
93 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46848474 |
94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.46353773 |
95 | Salmonella infection_Homo sapiens_hsa05132 | 0.45053220 |
96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44109718 |
97 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43846918 |
98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.41378410 |
99 | Leishmaniasis_Homo sapiens_hsa05140 | 0.41368265 |
100 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.38171283 |